The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(2-[5-Fluoro-1-(4-morpholin-4-yl-butyl)-1H-indol-3-yl]-thiazol-4-yl)-1H-pyrrolo[2,3-b]pyridine hydrobromide ID: ALA5179292
PubChem CID: 168272266
Max Phase: Preclinical
Molecular Formula: C26H27BrFN5OS
Molecular Weight: 475.59
Associated Items:
Names and Identifiers Canonical SMILES: Br.Fc1ccc2c(c1)c(-c1nc(-c3c[nH]c4ncccc34)cs1)cn2CCCCN1CCOCC1
Standard InChI: InChI=1S/C26H26FN5OS.BrH/c27-18-5-6-24-20(14-18)22(16-32(24)9-2-1-8-31-10-12-33-13-11-31)26-30-23(17-34-26)21-15-29-25-19(21)4-3-7-28-25;/h3-7,14-17H,1-2,8-13H2,(H,28,29);1H
Standard InChI Key: OFXKPOFBKPYJJU-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 39 0 0 0 0 0 0 0 0999 V2000
1.7189 -3.0969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9119 -2.9255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3598 -3.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4467 -3.3671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7018 -2.5826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2169 -1.9152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7018 -1.2480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4862 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2005 -1.0904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9148 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6294 -1.0904 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.9148 -2.3277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2005 -2.7401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4862 -2.3277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4467 -0.4635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3374 -0.2088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3374 0.6160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0047 1.1008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0047 1.9256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3941 2.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5653 3.2834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3453 3.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9612 2.9908 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7892 2.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2740 1.5133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7892 0.8459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4467 0.8709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9317 0.2036 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.2708 -2.4839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0158 -1.6995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5676 -1.0865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3744 -1.2579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6294 -2.0423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0776 -2.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1197 -0.0899 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 1 0
5 6 1 0
7 6 2 0
8 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
10 12 1 0
12 13 2 0
13 14 1 0
14 8 2 0
14 5 1 0
7 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
19 18 1 0
19 20 1 0
21 20 2 0
22 21 1 0
23 22 2 0
24 23 1 0
19 24 2 0
24 25 1 0
26 25 1 0
18 26 2 0
27 17 2 0
27 28 1 0
15 28 1 0
1 29 1 0
30 29 1 0
31 30 1 0
32 31 1 0
33 32 1 0
34 33 1 0
29 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 475.59Molecular Weight (Monoisotopic): 475.1842AlogP: 5.56#Rotatable Bonds: 7Polar Surface Area: 58.97Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.87CX Basic pKa: 7.68CX LogP: 4.78CX LogD: 4.32Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.31Np Likeness Score: -1.90
References 1. Carbone D, Vestuto V, Ferraro MR, Ciaglia T, Pecoraro C, Sommella E, Cascioferro S, Salviati E, Novi S, Tecce MF, Amodio G, Iraci N, Cirrincione G, Campiglia P, Diana P, Bertamino A, Parrino B, Ostacolo C.. (2022) Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification., 234 [PMID:35286926 ] [10.1016/j.ejmech.2022.114233 ]